The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Relay Therapeutics Inc’s stock clocked out at $8.98, up 8.59% from its previous closing price of $8.27. In other words, the price has increased by $8.59 from its previous closing price. On the day, 1.68 million shares were traded. RLAY stock price reached its highest trading level at $9.02 during the session, while it also had its lowest trading level at $8.26.
Ratios:
To gain a deeper understanding of RLAY’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 20.73 and its Current Ratio is at 20.73. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
On April 20, 2023, Jefferies Upgraded its rating to Hold which previously was Underperform but kept the price unchanged to $12.50.
Raymond James Upgraded its Outperform to Strong Buy on April 19, 2023, while the target price for the stock was maintained at $29.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 27 ’24 when Catinazzo Thomas sold 9,373 shares for $6.24 per share. The transaction valued at 58,493 led to the insider holds 330,430 shares of the business.
Bergstrom Donald A sold 648 shares of RLAY for $4,056 on Jun 27 ’24. The President, R&D now owns 526,779 shares after completing the transaction at $6.26 per share. On Jun 27 ’24, another insider, Adams Brian, who serves as the Chief Legal Officer of the company, sold 295 shares for $6.26 each. As a result, the insider received 1,847 and left with 325,472 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RLAY now has a Market Capitalization of 1192023040 and an Enterprise Value of 494718272. For the stock, the TTM Price-to-Sale (P/S) ratio is 33.74 while its Price-to-Book (P/B) ratio in mrq is 1.59. Its current Enterprise Value per Revenue stands at 14.004 whereas that against EBITDA is -1.359.
Stock Price History:
The Beta on a monthly basis for RLAY is 1.70, which has changed by -0.27110392 over the last 52 weeks, in comparison to a change of 0.24125004 over the same period for the S&P500. Over the past 52 weeks, RLAY has reached a high of $13.30, while it has fallen to a 52-week low of $5.70. The 50-Day Moving Average of the stock is 29.73%, while the 200-Day Moving Average is calculated to be 8.70%.
Shares Statistics:
It appears that RLAY traded 1.38M shares on average per day over the past three months and 1301810 shares per day over the past ten days. A total of 127.46M shares are outstanding, with a floating share count of 119.27M. Insiders hold about 10.15% of the company’s shares, while institutions hold 72.40% stake in the company. Shares short for RLAY as of 1719532800 were 8051982 with a Short Ratio of 5.83, compared to 1717113600 on 9601457. Therefore, it implies a Short% of Shares Outstanding of 8051982 and a Short% of Float of 7.79.
